![](/img/cover-not-exists.png)
PD-144 Tumor response augmentation with combination cetuximab(Erbitux®) and bevacizumab (Avastin®)
Hoang, T., Huang, S., Armstrong, E., Eickhoff, J., Harari, P.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80477-5
Date:
July, 2005
File:
PDF, 263 KB
english, 2005